Wellington Management Group LLP Kiniksa Pharmaceuticals, Ltd. Transaction History

Wellington Management Group LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.63 - $21.74 $1.49 Million - $1.84 Million	84,493 New	84,493 $1.67 Million
Q1 2023 May 12, 2023	SELL	$10.7 - $15.79 $62,188 - $91,771	-5,812 Reduced 2.33%	243,151 $2.62 Million
Q4 2022 Feb 13, 2023	SELL	$11.42 - $17.05 $214,730 - $320,591	-18,803 Reduced 7.02%	248,963 $3.73 Million
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $93,871 - $128,977	-9,618 Reduced 3.47%	267,766 $3.44 Million
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $216,290 - $287,689	-23,257 Reduced 7.74%	277,384 $2.76 Million
Q4 2021 Feb 11, 2022	SELL	$10.39 - $15.15 $1.07 Million - $1.55 Million	-102,559 Reduced 25.44%	300,641 $3.54 Million
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $4.01 Million - $5.79 Million	303,100 Added 302.8%	403,200 $5.62 Million
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $296,000 - $423,000	20,000 Added 24.97%	100,100 $1.77 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $1.22 Million - $2.04 Million	80,100 New	80,100 $1.23 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.